Safety, Tolerability, and Efficacy Study of Valoctocogene Roxaparvovec in Hemophilia A With Active or Prior Inhibitors

Clinical trial NCT04684940 · COMPLETED

Trial details

NCT number: NCT04684940
Sponsor: BioMarin Pharmaceutical
Status: COMPLETED
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Hemophilia A With Inhibitor Hemophilia A With Anti Factor VIII

Start date: 2020-12-10
Primary completion: 2026-04-20
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.